Vor Biopharma Inc. (VOR)
NASDAQ: VOR · Real-Time Price · USD
19.42
+0.10 (0.52%)
At close: Nov 13, 2026, 4:00 PM EST
19.47
+0.05 (0.26%)
After-hours: Nov 13, 2026, 7:30 PM EST

Vor Biopharma Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
1,354-695.98-116.91-117.86-92.09-68.9
Depreciation & Amortization
0.132.893.533.492.531.43
Loss (Gain) From Sale of Assets
-3.3-0.02---
Asset Writedown & Restructuring Costs
-177.38----
Stock-Based Compensation
35.3218.919.8513.3610.74.32
Other Operating Activities
-1,516340.583.890.073.573.19
Change in Accounts Payable
17.4210.932.242.851.110.41
Change in Other Net Operating Assets
-9.32-0.72-2.24-2.2-10.95-9.59
Operating Cash Flow
-119.17-142.71-99.66-100.29-85.14-69.14
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.51-0.94-0.23-1.07-8.46-3.89
Sale of Property, Plant & Equipment
-0.8----
Investment in Securities
-393.02-48.6697.0972.08-85.63-87.76
Investing Cash Flow
-393.53-48.896.8671.01-94.09-91.65

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Issuance of Common Stock
606.92505.3956.054.84117.14189.75
Repurchase of Common Stock
-0.35-0.25-0.33-1.19--
Other Financing Activities
-175.37-1.33-2.33-0.72--2.22
Financing Cash Flow
431.21503.8153.392.94117.14232.91

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
-81.49312.2950.59-26.35-62.172.12

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-119.68-143.65-99.89-101.36-93.61-73.04
Free Cash Flow Growth
------
Free Cash Flow Per Share
-2.70-14.55-29.07-30.17-47.33-43.69
Levered Free Cash Flow
-46.94-180.67-60.89-58.02-51.87-48.67
Unlevered Free Cash Flow
-46.94-180.67-60.89-58.02-51.87-48.67

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Change in Working Capital
8.110.210.010.65-9.84-9.19
SEC Filings: 10-K · 10-Q